Clinical Trials Epilepsy Tincture 
Canna Care Docs
JUNE 18, 2018
With increased attention and further legalization efforts in the United States, research surrounding the health applications are still in its infancy stages, but documentation and clinical trials continue to flow into the public sphere. Epilepsy Currents. CBD-enriched medical cannabis for intractable pediatric epilepsy.
The Cannigma
MARCH 7, 2022
When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. What can the current clinical trials tell us? As long as the product contains <0.3%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
FEBRUARY 28, 2023
The combined total from both channels — $58,293,034 — does not include CBD sales in licensed cannabis dispensaries or CBD products, such as vapes, tinctures, gummies, and other edibles sold online. (E-commerce Epilepsy Behav. E-commerce sales of CBD in the U.S. in 2021 reached $2 billion, according to Statistica.)
Kind Meds (Cannabis Education Blog)
NOVEMBER 18, 2020
CBD is consumable in many different forms, from simple oils to more robust tinctures, infused edible products, or inhaling smoke from dried cannabis flower through smoking or a vaporizer. Even doses higher than 1,000mg have been safely administered in testing, and CBD is considered safe for children for the treatment of epilepsy.
Cannabis Law Report
MARCH 7, 2022
When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. A contemporary history of the remedicalization of cannabis and the shifting boundaries between licit and illicit drugs.
The Cannigma
JUNE 15, 2021
Cannabis products such as oils, tinctures and creams are usually decarboxylated as part of their preparation. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock). It’s everywhere.
Kind Meds (Cannabis Education Blog)
JANUARY 9, 2019
Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood. The only side effects reported from Epidiolex clinical trials were sleepiness, sedation, insomnia, fatigue, diarrhea, rash, and some infections.
Expert insights. Personalized for you.
75 
Let's personalize your content